EUVIMEDAtrasti EUVIMED
Crossref

The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers

K Satoh, N Kan, T Okino, K Mise, S Yamasaki, T Harada, T Hori, K Ohgaki, T Tobe

Biotherapy · 1993

DOI: 10.1007/bf01877385 ↗

At a glance

Journal article in Biotherapy, 1993. Written by K Satoh and 8 co-authors. Institution: First Department of Surgery, Faculty of Medicine, Kyoto University, Japan. Major MEDLINE topics: Immunotherapy, Adoptive. Cited 7 times so far (Crossref); 26 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Santrauka nepasiekiama.

Subjects

MeSH terms (MEDLINE)

Immunotherapy, AdoptiveAdultAgedAntigens, NeoplasmColorectal NeoplasmsFemaleHumansInterleukin-2Liver NeoplasmsLymphocyte ActivationMaleMiddle AgedPicibanilStomach Neoplasms

Substances

Antigens, NeoplasmInterleukin-2Picibanil

Authors and institutions

  • First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

Cite

APA

Satoh, K., Kan, N., Okino, T., Mise, K., Yamasaki, S., Harada, T., Hori, T., Ohgaki, K., & Tobe, T. (1993). The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers. Biotherapy. https://doi.org/10.1007/bf01877385

Vancouver

Satoh K, Kan N, Okino T, Mise K, Yamasaki S, Harada T, et al. The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers. Biotherapy. 1993. doi:10.1007/bf01877385

BibTeX
@article{Satoh1993,
  author = {Satoh, K and Kan, N and Okino, T and Mise, K and Yamasaki, S and Harada, T and Hori, T and Ohgaki, K and Tobe, T},
  title = {The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers},
  journal = {Biotherapy},
  year = {1993},
  doi = {10.1007/bf01877385}
}
Start for free →